The impact of a supervised injecting facility on ambulance call-outs in Sydney, Australia

Addiction

Volumn 105, Issue 4, 2010, Pages 676-683

  Salmon, Allison M ^a   Van Beek, Ingrid ^b   Amin, Janaki ^a   Kaldor, John ^a   Maher, Lisa ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Sydney Medically Supervised Injecting Centre   (Australia)

Author keywords

Ambulance attendance; Drug consumption rooms; Injecting drug use; MSIC; Opioid related overdose; Overdose management; Supervised injecting facilities

Indexed keywords

DIAMORPHINE; NALOXONE; NARCOTIC AGENT; NARCOTIC ANTAGONIST;

AMBULANCE; ARTICLE; AUSTRALIA; DEMOGRAPHY; EMERGENCY HEALTH SERVICE; EPIDEMIOLOGY; EVALUATION; HARM REDUCTION; HEALTH CARE QUALITY; HEALTH SERVICE; HUMAN; INTOXICATION; ORGANIZATION AND MANAGEMENT; PREVENTIVE HEALTH SERVICE; STATISTICS; SUBSTANCE ABUSE; TIME; UTILIZATION REVIEW;

AMBULANCES; EMERGENCY MEDICAL SERVICES; EPIDEMIOLOGIC METHODS; HARM REDUCTION; HEALTH SERVICES NEEDS AND DEMAND; HEROIN; HUMANS; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; NEEDLE-EXCHANGE PROGRAMS; NEW SOUTH WALES; OVERDOSE; PROGRAM EVALUATION; RESIDENCE CHARACTERISTICS; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS;

EID: 77949399767     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2009.02837.x     Document Type: Article

References (34)

1. Dolan K., Kimber J., Fry C., Fitzgerald J., McDonald D., Frautmann F. Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug Alcohol Rev 2000 19 : 337 346.
2. Strathdee S. A., Pollini R. A 21st century Lazarus: the role of safer injecting sites in harm reduction and recovery. Addiction 2007 102 : 848 849.
3. Kerr T., Tyndall M., Li K., Montaner J., Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet 2005 366 : 316 318.
4. Stoltz J., Wood E., Small W., Li K., Tyndall M., Montaner J. et al. Changes in injecting practices associated with use of a medically supervised safer injection facility. J Public Health 2007 29 : 35 9.
5. Hedrich D. European Report on Drug Consumption Rooms. Lisbon : European Monitoring Centre for Drugs and Drug Addiction 2004.
6. Wood E., Kerr T., Small W., Li K., Marsh D. C., Montaner J. S. G. et al. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. Can Med Assoc J 2004 171 : 731 734.
7. Thein H. -H., Kimber J., Maher L., MacDonald M., Kaldor J. Public opinion towards supervised injecting centres and the Sydney Medically Supervised Injecting Centre. Int J Drug Policy 2005 16 : 275 280.
8. Salmon A. M., Thein H. -H., Kimber J., Kaldor J. M., Maher L. Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre? Int J Drug Policy 2007 18 : 46 53.
9. Firestone-Cruz M., Patra J., Fischer B., Rehm J., Kalousek K. Public opinion towards supervised injection facilities and heroin-assisted treatment in Ontario, Canada. Int J Drug Policy 2007 18 : 54 61.
10. Wood E., Tyndall M. W., Zhang R., Stoltz J., Lai C., Montaner J. S. G. et al. Attendance at supervised injecting facilities and use of detoxification services. N Engl J Med 2006 354 : 2512 2514.
11. Kerr T., Stoltz J., Tyndall M., Li K., Zhang R., Montaner J. et al. Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study. BMJ 2006 332 : 220 222.
12. Freeman K., Jones C. G. A., Weatherburn D. J., Rutter S., Spooner C. J., Donnelly N. The impact of the Sydney Medically Supervised Injecting Centre (MSIC) on crime. Drug Alcohol Rev 2005 24 : 173 184.
13. Wood E., Tyndall M., Lai C., Montaner J., Kerr T. Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime. Subst Abuse Treat Prev Policy 2006 1 : 1 4.
14. Milloy M. J. S., Kerr T., Tyndall M., Montaner J., Wood E. Estimated drug overdose deaths averted by North America's first medically-supervised safer injection facility. PLoS ONE 2008 3 : 3351.
15. Hall W. D., Ross J. E., Lynskey M. T., Law M. G., Degenhardt L. J. How many dependent heroin users are there in Australia? Med J Aust 2000 173 : 528 531.
16. Law M. G., Lynskey M., Ross J., Hall W. Back-projection estimates of the number of dependent heroin users in Australia. Addiction 2001 96 : 433 443.
17. NSW Government. New South Wales (NSW) Drug Summit 1999: Government Plan of Action. Sydney : NSW Government 2000.
18. van Beek I., Kimber J., Dakin A., Gilmour S. The Sydney Medically Supervised Injecting Centre: reducing harm associated with heroin overdose. Crit Public Health 2004 14 : 391 406.
19. NSW Parliament. Report on the Establishment or Trial of Safe Injecting Rooms: Joint Select Committee into Safe Injecting Rooms. Sydney : NSW Government 1998.
20. National Centre in HIV Epidemiology and Clinical Research. Sydney Medically Supervised Injecting Centre Evaluation Report 4: Evaluation of Service Operation and Overdose-Related Events. Sydney : University of New South Wales 2007.
21. Isselbacher K. J., Martin W., Kasper F. Harrison's Principles of Internal Medicine, 13th edn. New York : McGraw-Hill 1994.
22. Kimber J., Dolan K., Wodak A. International Survey of Supervised Injecting Centres (1999-2000) Technical Report 126. Sydney : University of New South Wales 2001.
23. Degenhardt L., Day C., Dietze P., Pointer S., Conroy E., Collins L. et al. Effects of a sustained heroin shortage in three Australian States. Addiction 2005 100 : 908 920.
24. Bammer G., Ostin R., Sengoz A. Using ambulance service records to examine nonfatal heroin overdose. Aust NZ J Public Health 1995 19 : 316 317.
25. Degenhardt L., Hall W., Adelstein B. Ambulance calls to suspected overdoses: New South Wales patterns July 1997 to June 1999. Aust NZ J Public Health 2001 25 : 447 450.
26. Dietze P., Jolley D., Cvetkovski S. Patterns and characteristics of ambulance attendance at heroin overdose at a local-area level in Melbourne, Australia: implications for service provision. J Urban Health 2003 80 : 248 260.
27. Clark M. J., Bates A. C. Nonfatal heroin overdoses in Queensland, Australia: an analysis of ambulance data. J Urban Health 2003 80 : 238 247.
28. Dietze P., Cvetkovski S., Rumbold G., Miller P. Ambulance attendance at heroin overdose in Melbourne: the establishment of a database of Ambulance Service records. Drug Alcohol Rev 2000 19 : 27 33.
29. Hargreaves K., Lenton S., Phillips M., Swensen G. Potential impacts on the incidence of fatal heroin-related overdose in Western Australia: a time-series analysis. Drug Alcohol Rev 2002 21 : 321 327.
30. Gossop M., Griffiths P., Williamson S., Strang J. Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. BMJ 1996 313 : 402.
31. Day C., Degenhardt L., Gilmour S., Hall W. Effects of a reduction in heroin supply on injecting drug use: analysis of data from needle and syringe programmes. BMJ 2004 329 : 428 429.
32. Beletsky L., Davis C. S., Anderson E., Burris S. The law (and politics) of safe injection facilities in the United States. Am J Public Health 2008 98 : 231.
33. Kerr T., Kimber J., Rhodes T. Drug use settings: an emerging focus for research and intervention. Int J Drug Policy 2007 18 : 1 4.
34. Darke S., Kaye S., Ross J. Geographical injecting locations among injecting drug users in Sydney, Australia. Addiction 2001 96 : 241 246.